(Select all that apply): A nurse is caring for a patient with Osteosarcoma.
What are appropriate nursing interventions for this patient? Select all that apply.

Choice B rationale:

Metastasis to the lungs and other bones is a significant concern for Osteosarcoma patients.

Osteosarcoma has a high propensity to metastasize, and the lungs are one of the most common sites for metastatic spread.

Additionally, metastasis to other bones can occur, further complicating the patient's condition.

Monitoring for metastasis and early detection are essential to guide treatment decisions and improve outcomes.

Choice A rationale:

Gastrointestinal bleeding is not a common complication of Osteosarcoma.

While Osteosarcoma primarily affects the bones, it can potentially invade nearby soft tissues, but gastrointestinal bleeding is not a characteristic complication associated with this cancer.

Choice C rationale:

Allergic reactions to chemotherapy are a concern but not a specific complication of Osteosarcoma itself.

Allergic reactions can occur with various medications, including chemotherapy drugs, but they are not unique to Osteosarcoma patients.

Choice D rationale:

Development of autoimmune disorders is not a known complication of Osteosarcoma.

Osteosarcoma primarily involves the growth of malignant bone tissue and is not typically associated with autoimmune-related issues.

Choice A rationale:

Radiation therapy.

Rationale: Radiation therapy is not commonly used as the primary treatment modality for Osteosarcoma.

While it may be used in certain situations to shrink tumors or manage symptoms, the primary treatment approach for Osteosarcoma typically involves a combination of surgery and chemotherapy.

Choice B rationale:

Chemotherapy.

Rationale: This statement is accurate.

Chemotherapy is commonly used as a part of the multimodal treatment approach for Osteosarcoma.

It is usually administered before surgery to shrink the tumor and after surgery to target any remaining cancer cells.

Chemotherapy drugs like methotrexate and cisplatin are commonly used in Osteosarcoma treatment protocols.

Choice C rationale:

Hormone therapy.

Rationale: Hormone therapy is not a standard treatment for Osteosarcoma.

Osteosarcoma is not a hormone-sensitive cancer, so hormone therapy is not effective in its management.

Choice D rationale:

Physical therapy.

Rationale: Physical therapy may be used as part of the comprehensive care plan for Osteosarcoma patients, especially after surgery or during the recovery phase.

However, it is not a primary treatment modality for the disease itself.